Filing Overview
Registrant: Jupiter Wellness, Inc. (the supplied metadata identifies BONK, Inc., but the filing names Jupiter Wellness, Inc.). This Form 8-K was filed for events occurring August 14–15, 2023 and was signed August 21, 2023.
Business Context and Transaction
Jupiter Wellness and SRM Entertainment, Inc. completed the separation of their businesses under an amended exchange agreement. SRM completed its initial public offering of 1,250,000 shares at $5.00 per share, before underwriting discounts and commissions, and became a separate public company.
- Jupiter distributed 2,000,000 SRM shares to its stockholders and certain warrant holders based on a July 7, 2023 record date.
- After the distribution, Jupiter retained 4,500,000 SRM shares and remained SRM’s largest shareholder.
- Jupiter ceased consolidating SRM’s financial results from the separation date forward.
- SRM assumed Douglas McKinnon’s employment agreement under an assignment effective August 14, 2023.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity balances, or other operating financial metrics. The disclosed IPO raised gross proceeds of $6.25 million for SRM before underwriting discounts and commissions; the filing does not state net proceeds.
Material Changes Versus the Prior Period
- SRM’s financial results will no longer be consolidated into Jupiter’s financial statements after August 14, 2023.
- Jupiter’s ownership interest in SRM changed through the distribution, leaving Jupiter with 4,500,000 SRM shares.
- Douglas McKinnon resigned as Jupiter’s CFO in connection with the transfer of his employment agreement to SRM.
- Markita L. Russell was appointed Jupiter’s CFO on August 15, 2023. She previously served as SRM’s controller.
- Anti-dilution adjustments reduced the exercise price of 8,631,754 warrants issued in January 2023 from $1.00 to $0.932 per share and increased the warrant count to 9,260,554.
Management Commentary, Risks and Unusual Items
The filing contains no financial guidance or detailed operating outlook. The separation, change in financial statement consolidation, distribution of SRM shares, and warrant anti-dilution adjustment are the principal unusual items.
Mr. McKinnon did not report any disagreement with Jupiter concerning its operations, policies, or practices. The filing states that there were no reportable related-party transactions or special arrangements associated with Ms. Russell’s appointment.
Investor Verification Checklist
- Verify the registrant’s identity, because the provided metadata refers to BONK, Inc., while the filing identifies Jupiter Wellness, Inc. and ticker JUPW.
- Review the exchange and separation agreements to determine the precise ownership, distribution, governance, and ongoing obligations between Jupiter and SRM.
- Confirm how Jupiter accounts for its remaining 4,500,000-share SRM investment after deconsolidation.
- Assess the effect of the warrant repricing and increase in warrant count on potential dilution.
- Review SRM’s IPO prospectus and final offering documents for net proceeds, underwriting costs, use of proceeds, and post-IPO capitalization.
- Confirm the transition of CFO responsibilities and any subsequent management or reporting changes.